Swarm Oncology
PrivateLast Round
Seed
Mar 5, 2026
Total Funding Raised
$10.3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Swarm Oncology is a biotechnology company that develops personalized T-cell therapies designed to treat advanced solid cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Swarm Oncology Comparables
Compare Swarm Oncology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Recursion Pharmaceuticals | 74% | |
| T-Therapeutics | 66% | |
| KSQ Therapeutics | 66% |
Swarm Oncology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 5, 2026 | ||||
| Grant | Sep 25, 2024 |
Swarm Oncology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Delin Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 360% MoM.
- Mar 5, 2026
$8.2M round led by Delin Ventures
Swarm Oncology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Swarm Oncology's valuation, stock price, and market status.
Is Swarm Oncology a public or private company?
Swarm Oncology is a private company.
What is the current stock price of Swarm Oncology?
Swarm Oncology is a private company with no public stock price. Caplight tracks Swarm Oncology's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Swarm Oncology worth (valuation)?
Valuation information for Swarm Oncology is not publicly available.
Can I buy Swarm Oncology stock?
Swarm Oncology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Swarm Oncology's last funding round?
Swarm Oncology's most recent funding round was Seed on March 5, 2026.
Who are the main investors in Swarm Oncology?
Key investors in Swarm Oncology include Delin Ventures.
Will Swarm Oncology IPO soon?
No public IPO plans have been announced for Swarm Oncology.
How can I track Swarm Oncology secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Swarm Oncology's secondary market activity and sign up for updates.